• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素 II 通过 ANG 1-7/MAS-1 依赖性途径介导肾小管细胞上皮-间质转化。

Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways.

机构信息

Danielle Alberti Memorial Centre for Diabetic Complications, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.

出版信息

Am J Physiol Renal Physiol. 2010 Sep;299(3):F585-93. doi: 10.1152/ajprenal.00538.2009. Epub 2010 Jun 16.

DOI:10.1152/ajprenal.00538.2009
PMID:20554647
Abstract

Epithelial-to-mesenchymal transformation (EMT) of tubular cells into a myofibroblastic phenotype is an important mediator of renal scarring in chronic nephropathy. This study examines the role of the renin-angiotensin system (RAS) in this process. NRK-52E cells were exposed to angiotensin (ANG) II and ANG 1-7 in the presence or absence of inhibitors and agonists of RAS signaling. EMT was assessed at 3 days by expression of alpha-smooth muscle actin (alpha-SMA) and E-cadherin and the induction of a myofibroblastic phenotype. Expression of fibrogenic growth factors and matrix proteins was assessed by RT-PCR and immunofluorescence microscopy. To confirm findings in vivo, rats were also infused with ANG 1-7 (24 microg*kg(-1)*h(-1)) or saline via an osmotic minipump for 10 days, and renal fibrogenesis was then assessed. Treatment of NRK-52E cells with ANG II induced characteristic changes of EMT. Selective blockade of the AT(1) receptor or the AT(2) receptor failed to inhibit ANG II-induced EMT. However, blockade of the ANG 1-7 receptor, Mas-1, was able to prevent ANG II-dependent EMT. To confirm these findings, both ANG 1-7 and the selective Mas receptor agonist, AVE-0991, were able to induce NRK-52E cells in a dose-dependent manner. Exposing cells to recombinant ACE2 was also able to induce EMT. In addition, an infusion of ANG 1-7 induced the tubular expression of alpha-SMA and the expression of matrix proteins in the kidney. ANG II is a potent stimulus for EMT, but not through conventional pathways. This study points to the possible limitations of conventional RAS blockade, which not only fails to antagonize this pathway, but also may enhance it via augmenting the synthesis of ANG 1-7.

摘要

上皮-间充质转化(EMT)管状细胞成肌成纤维表型是慢性肾病肾瘢痕形成的重要介质。本研究探讨了肾素-血管紧张素系统(RAS)在这个过程中的作用。NRK-52E 细胞在存在或不存在 RAS 信号转导抑制剂和激动剂的情况下,暴露于血管紧张素(ANG)II 和 ANG 1-7 中。在第 3 天通过表达α-平滑肌肌动蛋白(α-SMA)和 E-钙粘蛋白和诱导肌成纤维表型来评估 EMT。通过 RT-PCR 和免疫荧光显微镜评估纤维发生生长因子和基质蛋白的表达。为了在体内证实发现,还通过渗透微型泵向大鼠输注 ANG 1-7(24μg*kg(-1)*h(-1))或盐水 10 天,然后评估肾纤维化。用 ANG II 处理 NRK-52E 细胞诱导 EMT 的特征变化。选择性阻断 AT(1)受体或 AT(2)受体不能抑制 ANG II 诱导的 EMT。然而,阻断 ANG 1-7 受体,Mas-1,能够防止 ANG II 依赖性 EMT。为了证实这些发现,ANG 1-7 和选择性 Mas 受体激动剂 AVE-0991 都能够以剂量依赖性方式诱导 NRK-52E 细胞。暴露于重组 ACE2 的细胞也能够诱导 EMT。此外,ANG 1-7 的输注诱导肾小管中 α-SMA 的表达和肾脏中基质蛋白的表达。ANG II 是 EMT 的有效刺激物,但不是通过常规途径。这项研究指出了常规 RAS 阻断的可能局限性,它不仅不能拮抗这条途径,而且还可能通过增强 ANG 1-7 的合成来增强它。

相似文献

1
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways.血管紧张素 II 通过 ANG 1-7/MAS-1 依赖性途径介导肾小管细胞上皮-间质转化。
Am J Physiol Renal Physiol. 2010 Sep;299(3):F585-93. doi: 10.1152/ajprenal.00538.2009. Epub 2010 Jun 16.
2
Regulation of epithelial mesenchymal transition by the renin-angiotensin system: a role for klotho in renal tubular epithelial cells.肾素-血管紧张素系统对上皮间质转化的调节:klotho 在肾小管上皮细胞中的作用。
J Biol Regul Homeost Agents. 2020 Jan-Feb;34(1):57-67. doi: 10.23812/19-410-A-27.
3
The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.肾素-血管紧张素系统及其血管活性代谢产物血管紧张素-(1-7)在既往存在的胃溃疡愈合机制中的作用。Mas受体、一氧化氮、前列腺素和促炎细胞因子的参与情况。
J Physiol Pharmacol. 2016 Feb;67(1):75-91.
4
Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells.高糖培养的 NRK-52E 细胞中 TGF-β与 ACE2-Ang-(1-7)-Mas 通路的相互作用。
Mol Cell Endocrinol. 2013 Feb 5;366(1):21-30. doi: 10.1016/j.mce.2012.11.004. Epub 2012 Nov 19.
5
Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.血管紧张素II与血管紧张素-(1-7)通过激活大鼠肾系膜细胞上的血管紧张素I型受体和Mas受体产生的拮抗作用。
Regul Pept. 2012 Aug 20;177(1-3):12-20. doi: 10.1016/j.regpep.2012.04.002. Epub 2012 May 1.
6
Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.血管紧张素 -(1 - 7)抑制血管紧张素II刺激的近端肾小管细胞中丝裂原活化蛋白激酶的磷酸化。
Kidney Int. 2006 Jun;69(12):2212-8. doi: 10.1038/sj.ki.5001509. Epub 2006 May 3.
7
Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.血管紧张素 -(1 - 7)减轻大鼠梗阻性肾病所致的肾损伤。
PLoS One. 2015 Nov 10;10(11):e0142664. doi: 10.1371/journal.pone.0142664. eCollection 2015.
8
Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway.β-酪蛋白衍生七肽在高糖水平下可防止NRK-52E细胞发生上皮-间质转化:血管紧张素II-转化生长因子-β1途径的参与
Peptides. 2015 Aug;70:37-44. doi: 10.1016/j.peptides.2015.04.002. Epub 2015 Apr 14.
9
Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.血管紧张素 AT1 受体激活介导高糖诱导的肾近端小管细胞上皮-间充质转化。
Clin Exp Pharmacol Physiol. 2010 Sep;37(9):e152-7. doi: 10.1111/j.1440-1681.2010.05421.x. Epub 2010 Jun 25.
10
[Role of angiotensin II and JAK2 signal pathway in transdifferentation of renal tubular cells in mice after acute ischemic followed by reperfusion].[血管紧张素II及JAK2信号通路在小鼠急性缺血再灌注后肾小管细胞转分化中的作用]
Zhonghua Bing Li Xue Za Zhi. 2009 Jul;38(7):466-71.

引用本文的文献

1
Angiotensin‑converting enzyme 2 expression in human tumors: Implications for prognosis and therapy (Review).血管紧张素转换酶2在人类肿瘤中的表达:对预后和治疗的影响(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8934. Epub 2025 Jun 27.
2
Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD.ASC联合RAAS阻断疗法在实验性晚期慢性肾脏病中的协同肾脏保护作用
Stem Cells Int. 2022 Mar 25;2022:5111782. doi: 10.1155/2022/5111782. eCollection 2022.
3
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.
肺癌模型揭示严重急性呼吸综合征冠状病毒 2 诱导的上皮间质转化导致 2019 年冠状病毒病发病机制。
J Thorac Oncol. 2021 Nov;16(11):1821-1839. doi: 10.1016/j.jtho.2021.07.002. Epub 2021 Jul 16.
4
The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.肾素-血管紧张素系统在肿瘤干细胞生态位中的作用。
J Histochem Cytochem. 2021 Dec;69(12):835-847. doi: 10.1369/00221554211026295. Epub 2021 Jun 24.
5
Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.血管紧张素-(1-7):急性肾损伤的潜在治疗方法——从新冠疫情中获得的见解
J Clin Med. 2021 Mar 13;10(6):1200. doi: 10.3390/jcm10061200.
6
Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.血管紧张素转换酶2在泛癌中的预后及免疫价值
Front Mol Biosci. 2020 Sep 1;7:189. doi: 10.3389/fmolb.2020.00189. eCollection 2020.
7
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.肺癌模型显示,SARS-CoV-2诱导的上皮-间质转化促成了COVID-19的病理生理过程。
bioRxiv. 2021 Jan 28:2020.05.28.122291. doi: 10.1101/2020.05.28.122291.
8
Interaction between Mas1 and AT1RA contributes to enhancement of skeletal muscle angiogenesis by angiotensin-(1-7) in Dahl salt-sensitive rats.Mas1 与 AT1RA 的相互作用促进血管紧张素-(1-7)增强 Dahl 盐敏感大鼠骨骼肌血管生成。
PLoS One. 2020 Apr 23;15(4):e0232067. doi: 10.1371/journal.pone.0232067. eCollection 2020.
9
Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease.转化生长因子-β介导的NLRP3-高迁移率族蛋白B1激活在血管紧张素II诱导的大鼠慢性肾脏病肾小管间质纤维化中的作用
Front Cell Dev Biol. 2020 Feb 5;8:1. doi: 10.3389/fcell.2020.00001. eCollection 2020.
10
The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.糖尿病肾病的新生物学:机制与治疗意义。
Endocr Rev. 2020 Apr 1;41(2):202-31. doi: 10.1210/endrev/bnz010.